Correction: Detailed statistical analysis plan for ALBINO: effect of Allopurinol in addition to hypothermia for hypoxic-ischemic Brain Injury on Neurocognitive Outcome - a blinded randomized placebo-controlled parallel group multicenter trial for superiority (phase III)

Affiliations

¹ Center for Pediatric Clinical Studies (CPCS), University Hospital Tuebingen, Tuebingen, Germany. Corinna.Engel@med.uni-tuebingen.de.
² Universitätsklinikum C. G. Carus - Medizinische Fakultät der TU Dresden, Dresden, Germany.
³ Universitair Medisch Centrum Utrecht, Utrecht, The Netherlands.
⁴ University Hospitals Leuven, Leuven, Belgium.
⁵ UniversitaetsSpital Zuerich, Zuerich, Switzerland.
⁶ Medizinische Universitaet Wien, Wien, Austria.
⁷ Hospital Universitario y Politécnico La Fe, Valencia, Spain.
⁸ Centro Hospitalar Universitário São João Porto, Porto, Portugal.
⁹ Oslo Uni- versitetssykehus HF, Oslo, Norway.
¹⁰ Azienda sanitaria universitaria integrata di Udine, Udine, Italy.
¹¹ Helsinki University Hospital (HUS), Helsinki, Finland.
¹² Department of Neonatology, Poznan University of Medical Sciences, Poznan, Poland.
¹³ Tartu University Hospital, Tartu, Estonia.
¹⁴ ACE Pharmaceuticals BV, Zeewolde, The Netherlands.
¹⁵ Center for Pediatric Clinical Studies (CPCS), University Hospital Tuebingen, Tuebingen, Germany.
¹⁶ University Hospital Tuebingen, Calwerstr. 7, 72076, Tuebingen, Germany.

Published Erratum

Corinna Engel et al. Trials. 2024.

. 2024 Mar 15;25(1):192.

doi: 10.1186/s13063-024-08031-x.

¹ Center for Pediatric Clinical Studies (CPCS), University Hospital Tuebingen, Tuebingen, Germany. Corinna.Engel@med.uni-tuebingen.de.
² Universitätsklinikum C. G. Carus - Medizinische Fakultät der TU Dresden, Dresden, Germany.
³ Universitair Medisch Centrum Utrecht, Utrecht, The Netherlands.
⁴ University Hospitals Leuven, Leuven, Belgium.
⁵ UniversitaetsSpital Zuerich, Zuerich, Switzerland.
⁶ Medizinische Universitaet Wien, Wien, Austria.
⁷ Hospital Universitario y Politécnico La Fe, Valencia, Spain.
⁸ Centro Hospitalar Universitário São João Porto, Porto, Portugal.
⁹ Oslo Uni- versitetssykehus HF, Oslo, Norway.
¹⁰ Azienda sanitaria universitaria integrata di Udine, Udine, Italy.
¹¹ Helsinki University Hospital (HUS), Helsinki, Finland.
¹² Department of Neonatology, Poznan University of Medical Sciences, Poznan, Poland.
¹³ Tartu University Hospital, Tartu, Estonia.
¹⁴ ACE Pharmaceuticals BV, Zeewolde, The Netherlands.
¹⁵ Center for Pediatric Clinical Studies (CPCS), University Hospital Tuebingen, Tuebingen, Germany.
¹⁶ University Hospital Tuebingen, Calwerstr. 7, 72076, Tuebingen, Germany.

No abstract available

Erratum for

Detailed statistical analysis plan for ALBINO: effect of Allopurinol in addition to hypothermia for hypoxic-ischemic Brain Injury on Neurocognitive Outcome - a blinded randomized placebo-controlled parallel group multicenter trial for superiority (phase III).
Engel C, Rüdiger M, Benders MJNL, van Bel F, Allegaert K, Naulaers G, Bassler D, Klebermaß-Schrehof K, Vento M, Vilan A, Falck M, Mauro I, Metsäranta M, Vanhatalo S, Mazela J, Metsvaht T, van der Vlught R, Franz AR; ALBINO Study Group. Engel C, et al. Trials. 2024 Jan 24;25(1):81. doi: 10.1186/s13063-023-07828-6. Trials. 2024. PMID: 38267942 Free PMC article. Clinical Trial.

1. Engel C, et al. Detailed statistical analysis plan for ALBINO: effect of Allopurinol in addition to hypothermia for hypoxic-ischemic Brain Injury on Neurocognitive Outcome — a blinded randomized placebo-controlled parallel group multicenter trial for superiority (phase III) Trials. 2024;25:81. doi: 10.1186/s13063-023-07828-6. - DOI - PMC - PubMed